Skip to content

Improving maternal and fetal outcomes by using WHO next generation partograph: a randomized clinical trial in Rwanda.

Improving maternal and fetal outcomes by using WHO next generation partograph: a randomized clinical trial in Rwanda.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202504464806493
Enrollment
394
Registered
2025-04-15
Start date
2024-09-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

WHO new generation partograph
Traditional labour monitoring with partograph

Sponsors

Kigali University Teaching Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: ? Women =18 years of age, with an uncomplicated, singleton pregnancy, who have no known increased risk for complications eligible for vaginal delivery. ? Woman in labor whose cervical dilatation is = 5 cm with cephalic presentation. ? Participants are willing to give informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: ? Women aged less than 18 years old ? Medical comorbidities, such as hypertension, diabetes mellitus, renal disease, or pulmonary disease ? Obstetrical complications, such as preterm birth, multiple gestation, previous CD, breech position, postdated pregnancy, or bad obstetrical history (any previous outcome that can adversely affect the current pregnancy outcome) ? Those who undergo cesarean delivery in the latent phase ? Women in advanced labor whose cervical dilatation is 5 cm and non-cephalic presentation ? Multiple pregnancy ? Women with fetal malformations or fetal death ? Pregnant women that the hospital’s doctor deems inappropriate for the study

Design outcomes

Primary

MeasureTime frame
MATERNAL OUTCOMES: the following will be maternal outcome that will be evaluated: prevention of primary cesarean section, Duration of labour, Use of Oxytocin, acceptability of the method. FETAL OUTCOMES : fetal outcomes that will be evaluated will be: Apgar score at birth, NICU admission

Secondary

MeasureTime frame
Maternal Secondary outcomes will be: postpartum hemorrhage, overmedicalisation. Fetal secondary outcomes will be: Neonatal infection

Countries

Rwanda

Contacts

Public ContactANASTHASE IRUMVA

Obgyne Resident. University of Rwanda

iranastase@gmail.com+250783968957

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026